Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells

被引:173
作者
Cucak, Helena [1 ]
Yrlid, Ulf [2 ,3 ]
Reizis, Boris [4 ]
Kalinke, Ulrich [5 ,6 ]
Johansson-Lindbom, Bengt [1 ]
机构
[1] Lund Univ, Immunol Sect, S-22184 Lund, Sweden
[2] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Mucosal Immunobiol & Vaccine Ctr MIVAC, S-40530 Gothenburg, Sweden
[3] Swedish Fdn Strateg Res, S-40530 Gothenburg, Sweden
[4] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA
[5] Ctr Expt & Clin Infect Res, TWINCORE, D-30625 Hannover, Germany
[6] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany
基金
英国医学研究理事会;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CXC CHEMOKINE RECEPTOR-5; B-CELL; IMMUNE-RESPONSE; ANTIBODY-RESPONSES; IFN; GENERATION; ALPHA/BETA; INTERLEUKIN-21; AUTOIMMUNITY;
D O I
10.1016/j.immuni.2009.07.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T follicular helper (Tfh) cells represent a recently defined CD4(+) T cell subset characterized by the expression of the chemokine receptor CXCR5 and an enhanced ability to support B cells to mount antibody responses. Here, we demonstrate that lymph-node-resident CXCR5(+) Tfh cells and gut-homing integrin alpha(4)beta(7)-expressing T helper cells are generate as separate subsets in the gut-draining mesenteric lymph nodes. Type I interferon signaling in dendritic cells and in nonhematopoietic cells selectively stimulates Tfh cell development in response to antigen in conjunction with Toll-like receptor (TLR)3 or TLR4 agonists. Consistent with this, the ability of dendritic cells to produce the cytokine IL-6, required for in vivo Tfh differentiation, and antibody affinity maturation are both reduced in absence of type I interferon signaling. Thus, our results identify type I interferon as a natural adjuvant that selectively supports the generation of lymph node resident Tfh cells.
引用
收藏
页码:491 / 501
页数:11
相关论文
共 59 条
[1]   The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo [J].
Akiba, H ;
Takeda, K ;
Kojima, Y ;
Usui, Y ;
Harada, N ;
Yamazaki, T ;
Ma, J ;
Tezuka, K ;
Yagita, H ;
Okumura, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (04) :2340-2348
[2]   In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines [J].
Ansel, KM ;
McHeyzer-Williams, LJ ;
Ngo, VN ;
McHeyzer-Williams, MG ;
Cyster, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) :1123-1134
[3]   Type I interferon in systemic lupus erythematosus and other autoimmune diseases [J].
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2006, 25 (03) :383-392
[4]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[5]   Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies [J].
Bengtsson, AA ;
Sturfelt, G ;
Truedsson, L ;
Blomberg, J ;
Alm, G ;
Vallin, H ;
Rönnblom, L .
LUPUS, 2000, 9 (09) :664-671
[6]   MATURATION OF THE IMMUNE-RESPONSE IN GERMINAL-CENTERS [J].
BEREK, C ;
BERGER, A ;
APEL, M .
CELL, 1991, 67 (06) :1121-1129
[7]   ALPHA-4-BETA-7-INTEGRIN MEDIATES LYMPHOCYTE BINDING TO THE MUCOSAL VASCULAR ADDRESSIN MADCAM-1 [J].
BERLIN, C ;
BERG, EL ;
BRISKIN, MJ ;
ANDREW, DP ;
KILSHAW, PJ ;
HOLZMANN, B ;
WEISSMAN, IL ;
HAMANN, A ;
BUTCHER, EC .
CELL, 1993, 74 (01) :185-195
[8]   Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization [J].
Blink, EJ ;
Light, A ;
Kallies, A ;
Nutt, SL ;
Hodgkin, PD ;
Tarlinton, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (04) :545-554
[9]   Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice [J].
Braun, D ;
Geraldes, P ;
Demengeot, J .
JOURNAL OF AUTOIMMUNITY, 2003, 20 (01) :15-25
[10]   Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production [J].
Breitfeld, D ;
Ohl, L ;
Kremmer, E ;
Ellwart, J ;
Sallusto, F ;
Lipp, M ;
Förster, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (11) :1545-1551